Adrenal metastases: Difference between revisions

Jump to navigation Jump to search
m (Robot: Changing Category:DiseaseState to Category:Disease)
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 1: Line 1:
{{SI}}
{{SI}}
{{EH}}
 


== Overview ==
== Overview ==
Line 55: Line 55:


----
----
{{SIB}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WS}}
{{WS}}

Revision as of 20:45, 8 August 2012

WikiDoc Resources for Adrenal metastases

Articles

Most recent articles on Adrenal metastases

Most cited articles on Adrenal metastases

Review articles on Adrenal metastases

Articles on Adrenal metastases in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adrenal metastases

Images of Adrenal metastases

Photos of Adrenal metastases

Podcasts & MP3s on Adrenal metastases

Videos on Adrenal metastases

Evidence Based Medicine

Cochrane Collaboration on Adrenal metastases

Bandolier on Adrenal metastases

TRIP on Adrenal metastases

Clinical Trials

Ongoing Trials on Adrenal metastases at Clinical Trials.gov

Trial results on Adrenal metastases

Clinical Trials on Adrenal metastases at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adrenal metastases

NICE Guidance on Adrenal metastases

NHS PRODIGY Guidance

FDA on Adrenal metastases

CDC on Adrenal metastases

Books

Books on Adrenal metastases

News

Adrenal metastases in the news

Be alerted to news on Adrenal metastases

News trends on Adrenal metastases

Commentary

Blogs on Adrenal metastases

Definitions

Definitions of Adrenal metastases

Patient Resources / Community

Patient resources on Adrenal metastases

Discussion groups on Adrenal metastases

Patient Handouts on Adrenal metastases

Directions to Hospitals Treating Adrenal metastases

Risk calculators and risk factors for Adrenal metastases

Healthcare Provider Resources

Symptoms of Adrenal metastases

Causes & Risk Factors for Adrenal metastases

Diagnostic studies for Adrenal metastases

Treatment of Adrenal metastases

Continuing Medical Education (CME)

CME Programs on Adrenal metastases

International

Adrenal metastases en Espanol

Adrenal metastases en Francais

Business

Adrenal metastases in the Marketplace

Patents on Adrenal metastases

Experimental / Informatics

List of terms related to Adrenal metastases


Overview

Newer imaging technologies such as CT and MRI now indicate that the adrenal is a common site of metastases, and that adrenal metastases occur much more frequently than realized.

Epidemiology and Demographics

The primary tumor is a major determinant of the frequency of adrenal metastases. Primary tumors that frequently metasticize to the adrenal include:

  1. 50% of melanomas metastasize to the adrenals
  2. 30-40% of breast and lung cancers
  3. 10-20% of renal and gastrointestinal tumors

The most common sites for a primary tumor to metastasize to are

  1. Lung
  2. Liver
  3. Bone
  4. Adrenal gland

Screening

If adrenal metastases are present on an initial imaging survey, then this indicates that stage IV disease is present. This is critical, because the presence of adrenal metastases changes the choice of treatment in most case. The only except is ipsilateral renal cancer.

Pathophysiology & Etiology

Metastases are non calcified, vary in size and may be unilateral or bilateral. One complication of adrenal metastases is central necrosis with adrenal hemorrhage.

Diagnosis

History and Symptoms

Adrenal metastases are most often asymptomatic. In the event of extensive bilateral metastatic disease, signs and symptoms of adrenal insufficiency may be present which include:

Dizziness

Faintness

Fatigue

Weakness

Weight loss

Physical Examination

Usually non-revealing


MRI and CT

CT is first line imaging tool to screen the adrenal glands if a primary malignancy with a high for adrenal metastases (melanoma, lung cancer, and breast cancer) is present.

MRI and ultrasound are of limited use in the first line screening and evaluation of adrenal metastases.

PET

Positron emission tomography (PET) may demonstrate lower metabolic activity in an incidental adrenal adenoma vs a metastasis which may be more metabolically active.




Template:WS